Gilenya - direct healthcare professional communication (DHPC)

Fingolimod
DHPCHuman

Croatian is available via eTranslation, the European Commission's machine translation service.

Translate to Croatian | Important information about machine translation

Opis

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokumenti

Direct healthcare professional communication (DHPC): Gilenya (fingolimod): Updated recommendations to minimise the risk of drug-induced liver injury (DILI)

English (EN) (154.16 KB - PDF)

Prvo objavljeno:
Prikaži

Key facts

Medicine name
Gilenya
Active substance
Fingolimod
Therapeutic area (MeSH)
Multiple Sclerosis
Procedure number
EMEA/H/C/PSUSA/00001393/202002
Regulatory outcome
Variation
DHPC type
Periodic safety update report
Human ATC codes
L04AA27
Dissemination date

Share this page